Pfizer Settlement: An Over-the-Counter Drug Bust
Pharmaceutical mega-corporation Pfizer has agreed to pay $2.3 billion in civil and criminal penalties for its unlawful drug promotions. The company will pay the largest health care fraud fine in history for aiming their advertising dollars at patients, not doctors; promoting off-label uses of their drugs without FDA approval; and creating and distributing phony “independent” medical educational materials. The products at the heart of the case include Bextra, a drug approved to treat arthritis but marketed for other uses; and Wellbutrin, an anti-depressant promoted as a smoking cessation aid. Pfizer’s agreement to pay the penalty for their intent to defraud marks the culmination of a long and complex case. Tony West is the assistant attorney general for the Civil Division of the U.S. Department of Justice. He worked on the case and joins us to talk about drugs, advertising, and the law.
The story you just read is available to read for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, the reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
When you make a gift of $10 or more a month, we’ll invite you to a virtual behind-the-scenes tour of our newsroom to thank you for being with The World.